From: Fampridine and quality of life in individuals with multiple sclerosis
PERSEPP (%) (items) | Non-respondent | Respondent | ||||||
---|---|---|---|---|---|---|---|---|
Pre 1 | Pre 2 | Post 1 | Post 2 | Pre 1 | Pre 2 | Post 1 | Post 2 | |
Overall (33) | 63.1 (17.1) | 62.5 (16.6) | 66.3 (17.6) | 68.2 (18.6)* | 60.9 (15.1) | 62.4 (18.2) | 66.4 (18.3) | 70.6 (18.5) + |
Social support (5) | 85.5 (15.3) | 85.5 (12.7) | 87.7 (12.4) | 87.9 (12.9) | 91.2 (10.7) | 88.8 (23.3) | 87.2 (24.6) | 89.1 (24.6) |
Relationship dif. (9) | 54.8 (23.8) | 55.5 (24.4) | 62.1 (23.1) | 60.9 (22.8) | 46.4 (20) | 53.1 (23.9) | 51.9 (26.7) | 64.1 (25) † |
Fatigue (4) | 43 (30.6) | 43.6 (28.7) | 48.2 (32.4) | 47.6 (34.1) | 44.6 (32.7) | 45 (31.7) | 63.1 (32.7) ‡ | 66.2 (34) ‡ |
State of mind and sleep disor. (7) | 64.9 (24.8) | 64 (28.8) | 65.5 (27.7) | 67.8 (28.8) | 59.2 (25) | 65.1 (22.7) | 72.3 (24) | 73.5 (23.5) |
Time perspective (8) | 59.7 (21.7) | 58.1 (21.6) | 62 (25.3) | 66.7 (24.6)* | 58 (23.3) | 56 (23.1) | 63.5 (23.3) | 66.4 (21.3) |
Relapse (15) | 50.9 (26.1) | 53.5 (23.9) | 56.5 (25.8) | 56.9 (30.5) | 42 (19.2) | 42.1 (19.9) | 45.3 (16.7) | 52.7 (22.4) |
Modules | ||||||||
Coping (8) | 59.1 (20.5) | 58.8 (20.5) | 59.7 (20.8) | 59.2 (20.6) | 57.8 (15.8) | 56.7 (17.2) | 59.4 (22.2) | 60 (21.2) |
Symptoms (20) | 56.2 (19) | 56.8 (18.9) | 58.9 (19.3) ** | 64.1 (19.2) ** | 50.8 (14.9) | 51 (17.8) | 61 (14.1) ‡ | 60.1 (18.2) ‡ |
Treatment (5) | 86.4 (15.5) | 80.8 (21.3) | 79.8 (18.9) | 87.2 (14.7)*** | 87 (17.6) | 71.3 (36.4) | 84 (16.5) | 89.1 (11.9) |